Fintan Walton talks to Luc Dochez the CBO and Senior VP Business Development at Prosensa.
Prosensa: Luc Dochez. Developing therapies for neuromuscular diseases.
Share this Video
Related Videos In Neuromuscular Diseases
Tahseen Mozaffar: PROPEL Study Results
TouchNEUROLOGY caught up with Tahseen Mozaffar (University California, Irvine, CA, USA) to discuss the results from the PROPEL study (NCT03729362) investigating the use of AT-GAA for the treatment of late-onset Pompe disease. Questions: Could you tell us a little about late onset Pompe disease and the unmet needs in its treatment? (0:15) What is AT-GAA […]
Marianne de Visser, EAN 2020 – Pregnancy and Neuromuscular Disorders
Our editorial board member and EAN Secretary General, Marianne de Visser (Academic Medical Centre, Amsterdam, The Netherlands), shares her expert insight into pregnancy and neuromuscular disorders. Questions 1. How does pregnancy affect the symptoms of neuromuscular disorders? (0:05) 2. What are the implications of neuromuscular disorders and their treatments for the development of the fetus […]
Pamela Shaw, EAN 2019 – Moritz Romberg Lecture
Following her lecture at EAN 2019 in Oslo, Dr. Tom Jenkins, EAN eCommunciations board member and incoming editor-in-chief of EANpages, spoke to Prof. Dame Pamela Shaw following her Moritz Romberg Lecture: Translational Neuroscience to improve outcomes for motor neuron disease. Are we winning? at EAN 2019. Video produced by and shared with kind authorisation of […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!